Team
Portfolio
News
Scion Life Sciences
Contact
Investors
Team
Portfolio
News
Scion Life Sciences
Contact
Investors
Menu
Back to news
May 26, 2022
LumiraDx HbA1c Test Achieves CE Mark, Addresses Growing Global Need for Diabetes Screening and Monitoring with its Next-Generation Point of Care Diagnostic Platform